Scarborough Advisors’s CME Group CME Stock Holding History

Scarborough Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$270	–	470
2025 Q3	$270	Hold	1	–	–	﹤0.01%	432
2025 Q2	$276	Buy	+1	New	+$272	﹤0.01%	418
2024 Q3	–	Sell	-1	Closed	-$197	–	183
2024 Q2	$197	Buy	+1	New	+$207	﹤0.01%	411

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Scarborough Advisors's CME Position: Q4 2025 in Review

Scarborough Advisors sold out of CME Group (CME) in Q4 2025, closing a stake of 1 share — an estimated $270 sold.

Scarborough Advisors first reported a position in CME in Q2 2024 and held it in 3 quarters. The position peaked at $276 in Q2 2025. 1,736 funds tracked by Wall St. Rank hold CME as of Q4 2025.

Scarborough Advisors reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
Scarborough Advisors sold 1 CME Group share in Q4 2025, an estimated $270.
Scarborough Advisors first reported a position in CME Group in Q2 2024 and held it in 3 quarters.
Scarborough Advisors's CME Group position peaked at $276 in Q2 2025.
1,736 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on Scarborough Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.